Cyrus Emen

Cyrus with a degree in journalism. He ended up going into the education field and has been a teacher for the past six years. He is a television producer, writer, editor, professor, wife, mother, sister, daughter, friend and longtime, diehard Phillies fan.

Amazon.com, Inc. (NASDAQ:AMZN) Poor Run To Continue Into Q3 Earnings

by Cyrus Emen - on Oct 20th 2014 - No Comments

Tomahawk, WI 10/20/2014 (Basicsmedia) – Amazon.com, Inc. (NASDAQ:AMZN) has been a massive underperformer for the better part of the year according to CNBC’s Dan Nathan with the trend expected to continue heading into its third quarter earnings. The stock is already down by 24% for the year as profit margins continue to shrink. Amazon...

Avoid Ford Motor Company (NYSE:F) & General Motors Company (NYSE:GM) In Short Term: Adam Jonas

by Cyrus Emen - on Oct 9th 2014 - No Comments

Tomahawk, WI 10/09/2014 (Basicsmedia) – The swift changeover to Ford Motor Company (NYSE:F)’s new model F-150 is unlikely to go well with customers as earlier anticipated, according toMorgan Stanley’s analyst Adam Jonas. During an interview on CNBC, Jonas argued that a number of things will have to work to the automaker’s favor...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) Surges Ahead on Ebola Cure with a 60%-80% Survival Rate Drug

by Cyrus Emen - on Oct 1st 2014 - No Comments

Tomahawk, WI 10/01/2014 (Basicsmedia) – Sarepta Therapeutics Inc. (NASDAQ:SRPT) is more than ready to provide its Ebola Drug if called upon by health officials. Appearing on an interview on CNBC, CEO, Chris Garabedian, reiterated that the company has enough stock to handle up to 100 cases at the moment. The announcement that Sarepta...

Amazon.com, Inc. (NASDAQ:AMZN) is a Strong Sell: CNBC’s Carter Worth

by Cyrus Emen - on Sep 30th 2014 - No Comments

Tomahawk, WI 09/30/2014 (Basicsmedia) – A closer look at Amazon.com, Inc. (NASDAQ:AMZN) charts, one cannot fail to notice a disappointing trend that the company has maintained over the past few months compared to other players in the retail space. CNBC’s Carter Worth argues that Amazon remains a strong sale as it has underperformed...

Alibaba Group Holding Ltd (NYSE:BABA)’s IPO Aftermath Causing Stocks to Plummet Amidst Slowing Chinese Economy

by Cyrus Emen - on Sep 23rd 2014 - No Comments

Tomahawk, WI 09/23/2014 (Basicsmedia) – Alibaba Group Holding Ltd (NYSE:BABA)’s IPO came and went, leaving behind a series of effects that are being felt in the market with many stocks retracting back to lower trading margins. The Chinese government has made the situation even worse after stating it was’ contended with the slowing...

Alibaba Group Holding Ltd (NYSE:BABA) Grows Bigger Than Amazon, Ebay Combined

by Cyrus Emen - on Sep 19th 2014 - No Comments

Tomahawk, WI 09/19/2014 (Basicsmedia) – Alibaba Group Holding Ltd (NYSE:BABA) made a successful U.S. listing launch, raising $21.8 billion in the IPO and racing up more than 32% to $90 in the afternoon Friday. Shares touched $99.70 in the early session Friday. The company’s value of $231.7 billion dwarfs that of its larger rivals...

Alibaba Group Holding Ltd (NYSE:BABA) could have Upped Share Price Range: Rett Wallace

by Cyrus Emen - on Sep 19th 2014 - No Comments

Tomahawk, WI 09/19/2014 (Basicsmedia) – Alibaba Group Holding Ltd (NYSE:BABA) priced it’s IPO at the top price range of $68 a share, consequently closing the day with $21 billion in cash. Marking the biggest IPO in history. During an interview on CNBC, Triton Research co-founder, Rett Wallace, argued that the decision to close the...

Apple Inc. (NASDAQ:AAPL) and Facebook Inc. (NASDAQ:FB) are Cramer’s Top Picks in the Wake of Alibaba IPO

by Cyrus Emen - on Sep 16th 2014 - No Comments

Tomahawk, WI 09/16/2014 (Basicsmedia) – Alibaba is the talk of the town at the moment, with money managers going great lengths to raise capital for the upcoming IPO. CNBC’s Jim Cramer believes it is the perfect time to invest in Apple Inc. (NASDAQ:AAPL) and Facebook Inc. (NASDAQ:FB) as some investors continue to offload their stakes...

Orexigen Therapeutics, Inc. (NASDAQ:OREX) Obesity Pill Approval Fails to Spark Momentum in the Market

by Cyrus Emen - on Sep 15th 2014 - No Comments

Tomahawk, WI 09/15/2014 (Basicsmedia) – Patients suffering from obesity can finally heave a sigh of relief after the Food and Drug’s administration approved Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s obesity drug, Contrave. Contrary to expectations, the approval did not result in an uplift on the company’s stock in the market,...

Hertz Global Holdings, Inc. (NYSE:HTZ) Averts Possible Proxy Battle with Carl Icahn

by Cyrus Emen - on Sep 12th 2014 - No Comments

Tomahawk, WI 09/12/2014 (Basicsmedia) – Hertz Global Holdings, Inc. (NYSE:HTZ) has reached an agreement to add three candidates into its management team, proposed by the company’s largest shareholder Carl Icahn according to CNBC’s Scott Wapner. The agreement averts any possible proxy battle that could have befallen the company from...